Applications published 25 April 2007

Donepezil formulations
Actavis Group 1776089*

Stabilised prostaglandin compsn
Controlled Therapeutics (Scotland) 1776090*

Ocular implant made by a double extrusion process
Allergan 1776091*

Lipidated glycoprotein particles and methods of use
Ramot at Tel-Aviv University 1776092*

Compsns containing nicorandil, preparation method and use
Aventis Pharma 1776093*

Tablet coating compsn
Grain Processing Corp 1776094*

Pharmaceutical compsns comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists
Solvay Pharmaceuticals 1776095*

CRP lowering agent
Takeda Pharmaceutical 1776096*

Methods of treating ophthalmic conditions
Allergan 1776097*

Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypergonadism, elevated triglycerides and high cholesterol
Repros Therapeutics 1776098*

Methods for improved bioavailability of a renin inhibitor
Novartis 1776099*

Treatment of cancer using benzoic acid derivatives
New York University 1776100*

Vaginal health products
Kimberley-Clark Worldwide 1776101*

Preparations of stable pharmaceutical compsns of nateglinide and processes for their preparation
Ranbaxy Laboratories 1776102*

Ruthenium complexes for treating cancers
Universite Louis Pasteur 1776103*

Use of targeted oxidative therapeutic formulation in endotoxic treatment
Hofmann, Robert F 1776104*

Methods and compsns for inducing innate immune responses
Coley Pharmaceutical 1776105*

Heterocyclic derivatives for modulation of calcium channels
Vertex Pharmaceuticals 1776106*

Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
Wyeth 1776107*

Enoxamine formulations and their use in the treatment of PDE-III mediated diseases
Myogen 1776108*

Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
Schering-Plough 1776109*

Inhibitors of HSP90
Novartis 1776110*

Modulators of PPAR and methods of their preparation
Metabolex 1776111*

Heterocyclic compounds as pharmaceutical agents
Exelixis 1776112*

Pharmaceutical formulation based on antibiotic in microcapsule form
Flamel Technologies 1776113*

Combinations of gaboxadol and 5HT2A antagonists
Merck Sharp & Dohme 1776114*

Use of organic compounds
Novartis 1776115*

Veterinary compsn comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity
Intervet International 1776116*

Dual NK1/NK3 antagonists against schizophrenia
F Hoffmann-La Roche 1776117*

Iron chelators for treating radiocontrast-associated renal dysfunction
Shiva Biomedical 1776118*

Tetrahydro-naphthalene derivatives as glycocorticoid receptor modulators
Glaxo Group 1776119*

Novel uses of 2-phenyl-substituted imidazotriazinone derivatives
Bayer HealthCare 1776120*

Treatment of methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists
Omeros 1776121*

Use of glucocorticoid steroids for the treatment of muscular dystrophy
Santhera Pharmaceuticals (Schweiz) 1776122*

Risedronate compsns and their methods of use
Procter & Gamble 1776123*

Immune modulating oligonucleotides in connection with chemotherapeutic measures
Mologen 1776124*

Functionalised single walled carbon nanotubes
Hyperion Catalysis International 1776125*

Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
Cytori Therapeutics 1776126*

A method of improving anticancer effect of Pulsatillaw radix and a compsn prepared by the method
Kim, Song Bae 1776127*

Compsns for topical treatment
Altunkaya, Ali 1776128*

The use of paeonia and extracts thereof with with growth promoting activity in veterinary medicine and zootechnics
Indena 1776129*

PIN1-modulating compounds and methods of use thereof
Vernalis; Beth Israel Deaconess Medical Centre; The Salk Institute for Biological Studies 1776130*

Methods for treating premature infants
Voyager Pharmaceutical 1776131*

Naturiuretic compounds, conjugates and uses thereof
Nobex 1776132*

Peptidic vasopressing receptor agonists
Ferring 1776133*

C-MET kinase binding proteins
Amgen Mountain View 1776134*

Treatment of conditions involving demyelination
Biogen Idec 1776136*

Pharmaceutical compsn containing botulinum neurotoxin A2
Ipsen 1776137*

tRNA synthase fragments
Angiosyn 1776138*

Targeting damaged lung tissue
Pneumrx 1776139*

Methods of inhibiting viral replication
The Johns Hopkins University 1776140*

Dendritic cell vaccines for treating cancer made from embryonic stem cells
Geron 1776141*

IL-17 antagonists antibodies
Novartis 1776142*

Bifunctional derivatives of polyethylene glycol, their preparation and use
Universita ‘Degli Studi di Trieste 1776143*

Heat shock protein as a targeting agent for endothelium-specific in vivo transduction
General Electric 1776144*